Predicting Melanoma in Small- and Medium-Sized Congenital Nevi
Predictors of dermatoscopic melanoma were investigated in a study that revealed a novel finding.
Skin Cancer
Permanent Hair Dye Not Linked to Cancer Risk, Mortality
Use of permanent hair dye is not associated with the risk for most cancers or cancer mortality.
Prior History of SCC Could Be a Red Flag for Development of SCC in the Setting of CLL
In this study, a cohort of patients with newly diagnosed CLL was followed to identify the incidence of SCC skin cancer and its associated risk factors in this population.
Follow-up Calls After Mohs Surgery Do Not Boost Satisfaction
Postoperative follow-up telephone calls to patients after Mohs micrographic surgery (MMS) do not improve patient satisfaction.
Algorithm Aids Diagnosis of Atypical Melanocytic Skin Lesions
The influence of body location on the intuitive diagnosis performed in teledermoscopy by dermatologists of differing skill levels was investigated.
High Frequency Basal Cell Carcinoma—Who is at Risk?
A study sought to establish prevalence of HF-BCC in the US and the characterization of patients with HF-BCC in the US.
FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use
Hydrochlorothiazide is indicated for the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives.
Folds in Hutchinson’s Nail Sign Provide Useful Clinical Information in Subungual Melanoma
The extent of Hutchinson’s nail sign may be a useful prognostic indicator in patients with subungual melanoma.
Tecentriq Plus Cotellic and Zelboraf Approved for Advanced Melanoma
The approval was based on data from the multicenter, double-blind, placebo-controlled phase 3 IMspire150 study.
Pembrolizumab Use Supported in Advanced Melanoma
Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of a BRAFi with or without MEKi therapy.
-
Loading...
-
Loading...
Next post in Skin Cancer
